Onychomycosis Market Research Report 2030: Industry Analysis, Drugs, Epidemiology and Key Companies by DelveInsight | Moberg Pharma, Blueberry Therapeutics, Mycovia Pharmaceuticals, Bausch Health, Pfizer and Others
iCrowdNewswire
May 24, 2021
DelveInsight’s Onychomycosis Market Insights Report offers a detailed analysis of Disease, its causes, symptoms, diagnostics modalities, and treatment options.
The report also offers comprehensive insights into Onychomycosis market size, epidemiology, emerging therapies, market drivers, market barriers, ongoing Onychomycosis clinical trials, collaboration in the space, and key pharmaceutical companies actively pushing the growth of Onychomycosis market size forward in the 7MM [US, EU5(Germany, France, the United Kingdom, Spain, and Italy) and Japan].
Some of the key highlights from the Onychomycosis Market Insights:
- As per Delveinsight, Onychomycosis Market was estimated to be USD 3842.6 million in 2017.
- In 2017, Onychomycosis’s prevalent population in the United States was found to be 35,829,110.
- Spain reported the least number of prevalent cases in the 7MM.
- As per Delveinsight’s estimates, the total prevalent cases for Onychomycosis were highest in the United States, followed by Japan & France.
- MOB-015 (Moberg Pharma), which is expected to launch during the forecast period (2020–2030), is anticipated to be the most promising therapy amongst all the other desired drug candidates.
- According to DelveInsight’s analysis, no gender bias was observed in the case of Onychomycosis.
Onychomycosis Disease Overview:
Onychomycosis, the most common fungal nail infection that has been evaluated to account for about half of all nail diseases. It causes discoloration and thickening of the affected nail. Onychomycosis was initially believed to be caused predominantly by dermatophytes; however, new studies have unveiled that mixed infections & those caused by nondermatophyte molds are more prevalent than previously thought, especially in warmer climates.
Although not life-threatening, fungal nail infections are significant public health concerns due to their high prevalence, inadequate response to therapy & significant clinical, social and financial impact.
Onychomycosis Symptoms:
Symptoms include yellow or white nail discoloration, separation of the nail from the nail bed, thickening of the nail, Dry or scaly skin around the nail, Foul smell, Etc.
For more insights into Disease, treatment, and causes, reach out to Onychomycosis Treatment Landscape.
Onychomycosis Epidemiology Segmentation
The Onychomycosis Market report proffers epidemiological analysis for the study period 2017-30 in the 7MM segmented into:
- Onychomycosis Prevalence
- Severity Specific Onychomycosis Prevalence
- Diagnosed and Treatable Cases of Onychomycosis
Visit for more @ Onychomycosis Epidemiological Insights.
Onychomycosis Pipeline Therapies and Key Companies
- Moberg Pharma: MOB-015
- Blueberry Therapeutics: BB2603
- Mycovia Pharmaceuticals: VT-1161
- Bausch Health: Jublia//Clenafin (efinaconazole)
- Pfizer: Kerydin (tavaborole)
- Sato Pharmaceutical/Bausch Health: Luliconazole
- Sato Pharmaceutical/ Eisai: Nialin
- Meiji Seika Pharma: ME111
- NovaBiotics: NP213 (Novexatin)
- Halllux: HTS-519
- And Many Others
For more information, visit Onychomycosis Market Analysis, Patient Pool, and Emerging Therapies.
Scope of the Report
- 11 Years Forecast
- 7MM Coverage
- Descriptive overview of Onychomycosis, covering causes, signs and symptoms, pathophysiology, diagnosis, and currently available therapies
- Comprehensive insight into Onychomycosis epidemiology and treatment in the 7MM
- Current and emerging therapies for Onychomycosis
- Onychomycosis market drivers and barriers
Get in touch with our Business executive @ Onychomycosis Market Landscape Analysis.
Table of Contents
1 |
Key Insights |
2 |
Report Introduction |
3 |
Competitive Intelligence Analysis for Onychomycosis |
4 |
Onychomycosis Market Overview at a Glance |
5 |
Executive Summary of Onychomycosis |
6 |
Onychomycosis Epidemiology and Market Methodology |
7 |
Onychomycosis Epidemiology and Patient Population |
8 |
Onychomycosis Patient Journey |
9 |
Treatment Algorithm, Current Treatment, and Medical Practices |
10 |
Key Endpoints in Onychomycosis Clinical Trials |
11 |
Onychomycosis Marketed Therapies |
12 |
Onychomycosis Emerging Therapies |
13 |
Onychomycosis: 7 Major Market Analysis |
14 |
Attribute analysis |
15 |
Access and Reimbursement Overview of Onychomycosis |
16 |
KOL Reviews |
17 |
Case Reports |
18 |
Onychomycosis Market Drivers |
19 |
Onychomycosis Market Barriers |
20 |
SWOT Analysis |
21 |
Disclaimer |
21 |
DelveInsight Capabilities |
22 |
About DelveInsight |
Learn more about the report offerings @ Onychomycosis Market Outlook
Latest Blogs:
MedTech Industry: Commercial, Regulatory and Clinical Updates
Who is Going to be a Trendsetter in the Hereditary Deafness Market?
The Rising Burden of Substance Use Disorder And The Treatment Scenario
Related Blog: Onychomycosis therapeutics market: Impact of new topical anti-fungal drugs
Related Reports:
Adeno-Associated Virus Vectors in Gene Therapy Market
DelveInsight’s Adeno-Associated Virus Vectors in Gene Therapy Market Insight, Epidemiology and Market Forecast – 2030′ report will provide Adeno-Associated Virus Vectors in Gene Therapy Market, Epidemiological & Therapeutics market domain with a special focus on key companies such as Advernum Biotechnologies, Lysogene, uniQure, Spark Therapeutics, MeiraGTx, Rocket Pharmaceuticals, and several others.
ABSSSI Market
DelveInsight’s “ABSSSI Market Insights, Epidemiology, and Market Forecast-2030” report will provide Acute Bacterial Skin and Skin Structure Infections Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as Basilea Pharmaceutica, Motif Bio, Innovation Pharmaceuticals, Debiopharm, MicuRx Pharmaceuticals, Destiny Pharma, KBP Biosciences and several others.
Aspergillosis Market
DelveInsight’s ‘Aspergillosis Market Insights, Epidemiology and Market Forecast – 2030’ report will provide Aspergillosis Market, Epidemiological & Therapeutics market domain with special focus on key companies such as F2G, Zambon SpA, TFF Pharmaceuticals, Scynexis, Pulmocide, Pulmatrix, and several others.
Community-Acquired Bacterial Pneumonia Market
DelveInsight’s ‘Community-Acquired Bacterial Pneumonia Market Insights, Epidemiology and Market Forecast – 2030’ report will provide Community-Acquired Bacterial Pneumonia Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as Combioxin, BioAegis Therapeutics, Biotest, Tigenix, and several others.
Other Reports:
- Electrophysiology Devices Market
- Growth Hormone Deficiency Market
- Interventional Neuroradiology Market
- Intracranial Pressure Monitoring Devices Market
- Foot and Ankle Devices Market
About DelveInsight
DelveInsight is a leading Market Research & Business Consultant focused purely on life sciences. It helps pharma companies by providing them with end-to-end services to boost their performance.
Get access to all the Pharma & healthcare market research reports through our market research subscription-based platform PharmDelve.
Connect With Us at:
Contact Information:
Ankit Nigam
info@delveinsight.com
+91-9650213330
LinkedIn | Facebook | Twitter
Get Free Sample Copy of Report at: https://www.delveinsight.com/sample-request/onychomycosis-market